…
Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China, Europe, North America, and the Middle East. The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. It sells its products through direct distributors. The company serves manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company has a strategic partnership with Tigerbone Group Limited. Bon Natural Life Limited was founded in 2006 and is headquartered in Xi'an, the People's Republic of China.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Bon Natural Life Ltd is a NASDAQ-listed company whose publicly available disclosures do not provide a clear, detailed description of its operations or product lines. Because long-term growth drivers are not well-documented, investors should monitor future filings for evidence of scalable revenue streams, distribution expansion, or product development before assessing prospects.
Key investment risks include limited transparency and disclosure, low trading liquidity and small-cap share volatility, potential regulatory or cross-border compliance exposure, and execution risk tied to an unclear business strategy.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
| Income before tax | -1.71M | 0.72M | 5.55M | 7.51M | 5.43M |
| Minority interest | 0.05M | 0.05M | 0.04M | -0.00M | -0.02M |
| Net income | -1.99M | 0.40M | 4.60M | 6.24M | 4.59M |
| Selling general administrative | 4.75M | 3.35M | 2.33M | 2.24M | 1.32M |
| Selling and marketing expenses | - | 0.27M | 0.29M | 0.22M | 0.14M |
| Gross profit | 3.88M | 7.11M | 8.84M | 9.42M | 7.11M |
| Reconciled depreciation | 1.29M | 1.28M | 1.18M | 0.37M | 0.29M |
| Ebit | -1.34M | 1.02M | 5.79M | 7.92M | 5.89M |
| Ebitda | -0.06M | 2.30M | 6.98M | 8.29M | 6.18M |
| Depreciation and amortization | 1.29M | 1.28M | 1.18M | 0.37M | 0.29M |
| Operating income | -1.62M | 1.87M | 5.92M | 6.54M | 5.40M |
| Other operating expenses | 20.29M | 21.97M | 23.59M | 22.06M | 19.64M |
| Interest expense | 0.37M | 0.30M | 0.24M | 0.45M | 0.42M |
| Tax provision | 0.34M | 0.35M | 1.00M | 1.27M | 0.82M |
| Interest income | 0.00M | 0.00M | 0.01M | 0.00M | 0.00M |
| Net interest income | -0.37M | -0.30M | -0.23M | -0.45M | -0.41M |
| Income tax expense | 0.34M | 0.35M | 1.00M | 1.27M | 0.82M |
| Total revenue | 18.67M | 23.84M | 29.52M | 29.91M | 25.49M |
| Total operating expenses | 5.50M | 5.24M | 2.90M | 1.58M | 1.26M |
| Cost of revenue | 14.79M | 16.73M | 20.68M | 20.48M | 18.38M |
| Total other income expense net | -0.09M | -1.16M | -0.36M | 0.11M | -0.01M |
| Net income from continuing ops | -2.05M | 0.35M | 4.55M | 6.24M | 4.61M |
| Net income applicable to common shares | - | - | - | 6.24M | 4.59M |
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
| Total assets | 85.19M | 61.77M | 46.56M | 37.26M | 36.41M |
| Intangible assets | 6.42M | 0.78M | 1.00M | 0.37M | 0.41M |
| Other current assets | 8.71M | 26.33M | 2.36M | 0.28M | 5.19M |
| Total liab | 27.19M | 17.42M | 10.57M | 7.16M | 9.88M |
| Total stockholder equity | 57.55M | 43.91M | 35.48M | 29.56M | 26.01M |
| Other current liab | 7.04M | 2.50M | 4.86M | 1.35M | 5.34M |
| Common stock | 0.15M | 0.00M | 0.00M | 0.00M | 0.00M |
| Capital stock | 0.15M | 0.00M | 0.00M | 0.00M | 0.00M |
| Retained earnings | 16.63M | 18.74M | 18.70M | 14.68M | 9.19M |
| Other assets | - | - | - | 0.00M | 0.02M |
| Cash | 6.27M | 0.08M | 0.11M | 0.84M | 1.90M |
| Total current liabilities | 26.31M | 16.45M | 9.61M | 6.65M | 7.53M |
| Current deferred revenue | 0.22M | 0.51M | 0.11M | 0.19M | 1.10M |
| Net debt | 6.06M | 7.22M | 4.09M | 4.57M | 1.16M |
| Short term debt | 11.41M | 6.33M | 3.24M | 4.89M | 0.71M |
| Short long term debt | 11.33M | 6.18M | 3.01M | 4.63M | 0.49M |
| Short long term debt total | 12.32M | 7.30M | 4.20M | 5.41M | 3.06M |
| Other stockholder equity | 40.79M | 25.01M | 18.09M | 15.71M | 15.54M |
| Property plant equipment | - | - | - | 22.17M | 19.43M |
| Total current assets | 45.76M | 39.79M | 24.18M | 14.72M | 16.55M |
| Net tangible assets | - | - | - | 29.20M | 25.60M |
| Short term investments | - | - | 0.00M | 0.00M | 1.70M |
| Net receivables | 11.54M | 11.81M | 4.61M | 6.78M | 6.15M |
| Long term debt | 0.84M | 0.97M | 0.87M | 0.19M | 2.17M |
| Inventory | 19.24M | 1.57M | 0.99M | 1.72M | 1.60M |
| Accounts payable | 7.64M | 3.43M | 1.40M | 0.21M | 0.38M |
| Accumulated other comprehensive income | -0.03M | 0.16M | -1.31M | -0.83M | 1.27M |
| Non currrent assets other | - | 6.05M | -22.37M | - | - |
| Non current assets total | 39.43M | 21.97M | 22.37M | 22.54M | 19.86M |
| Capital lease obligations | 0.11M | 0.15M | 0.32M | 0.58M | 0.40M |
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
| Investments | 0.00M | -0.02M | -1.19M | -3.06M | -1.69M |
| Change to liabilities | - | - | - | -1.02M | -0.29M |
| Total cashflows from investing activities | -10.00M | -0.02M | -1.19M | -3.06M | -7.44M |
| Net borrowings | 4.78M | 3.15M | -0.88M | 2.26M | -5.40M |
| Total cash from financing activities | 15.45M | 8.76M | 1.16M | 2.26M | 5.35M |
| Change to operating activities | - | - | - | -0.32M | -0.08M |
| Net income | -1.99M | 0.42M | 4.61M | 6.24M | 4.61M |
| Change in cash | 5.61M | 0.55M | -0.73M | -1.06M | 1.85M |
| Begin period cash flow | 0.66M | 0.11M | 0.84M | 1.90M | 0.05M |
| End period cash flow | 6.27M | 0.66M | 0.11M | 0.84M | 1.90M |
| Total cash from operating activities | 0.14M | -7.72M | -0.65M | -0.19M | 4.05M |
| Issuance of capital stock | 10.67M | 5.60M | 2.03M | 0.00M | 11.27M |
| Depreciation | 1.29M | 1.28M | 1.18M | 0.37M | 0.29M |
| Other cashflows from investing activities | - | -0.01M | -0.45M | - | - |
| Change to inventory | -3.83M | -6.12M | -3.84M | -0.16M | -0.21M |
| Change to account receivables | -0.11M | -6.81M | 2.08M | -1.30M | -0.09M |
| Other cashflows from financing activities | - | 0.00M | 0.00M | 3.04M | 2.15M |
| Change to netincome | - | - | - | 0.04M | -0.17M |
| Capital expenditures | 4.37M | 0.01M | 0.06M | 4.74M | 4.75M |
| Change in working capital | -1.45M | -11.67M | 0.25M | -6.83M | -0.65M |
| Stock based compensation | 1.39M | 1.32M | 0.13M | 0.17M | 0.04M |
| Other non cash items | 2.30M | 2.25M | -6.70M | -0.16M | -0.26M |
| Free cash flow | -4.23M | -7.73M | -0.71M | -4.92M | -0.70M |
Sector: Basic Materials Industry: Specialty Chemicals
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| BON Bon Natural Life Ltd |
-0.01 0.50% |
1.04 | - | 2.35 | 0.74 | 0.19 | 1.04 | 5.49 |
| LIN Linde plc Ordinary Shares |
-7.46 1.46% |
502.75 | 33.77 | 28.90 | 6.56 | 5.42 | 7.03 | 18.92 |
| AIQUY Air Liquide SA ADR |
-0.53 1.28% |
40.87 | 30.69 | 24.81 | 4.70 | 4.10 | 4.36 | 15.61 |
| AIQUF L'Air Liquide S.A |
-4.87 2.34% |
203.00 | 29.78 | 22.68 | 4.54 | 3.98 | 4.50 | 15.90 |
| SHW Sherwin-Williams Co |
-0.11 0.03% |
339.72 | 33.33 | 27.40 | 3.38 | 20.60 | 3.88 | 21.36 |
Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China, Europe, North America, and the Middle East. The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. It sells its products through direct distributors. The company serves manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company has a strategic partnership with Tigerbone Group Limited. Bon Natural Life Limited was founded in 2006 and is headquartered in Xi'an, the People's Republic of China.
| Name | Title | Year Born |
|---|---|---|
| Mr. Yongwei Hu | Chairman & CEO | 1972 |
| Mr. Zhenchao Li | CFO & Director | 1966 |
| Ms. Yingchun Xue | Chief Operating Officer | 1974 |
| Mr. Jianli Liu | CTO & Chief Scientist | 1960 |
| Ms. Wenjuan Chen | Chief Marketing Officer | 1980 |
| Ms. Yingchun Xue | COO & Non-Independent Director | 1974 |
| Mr. Wang L. Lee | Chief Financial Officer | NA |
| Mr. Wang L. Lee | Chief Financial Officer | 1979 |
| Mr. Yongwei Hu | Chairman & CEO | 1973 |
| Mr. Xin Ma | Chief Financial Officer | 1976 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.